The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda.

PubWeight™: 2.79‹?› | Rank: Top 1%

🔗 View Article (PMC 2408615)

Published in PLoS Med on June 03, 2008

Authors

Godfrey Kigozi1, Ronald H Gray, Maria J Wawer, David Serwadda, Frederick Makumbi, Stephen Watya, Fred Nalugoda, Noah Kiwanuka, Lawrence H Moulton, Michael Z Chen, Nelson K Sewankambo, Fred Wabwire-Mangen, Melanie C Bacon, Renee Ridzon, Pius Opendi, Victor Sempijja, Absolom Settuba, Denis Buwembo, Valerian Kiggundu, Margaret Anyokorit, James Nkale, Nehemia Kighoma, Blake Charvat

Author Affiliations

1: Rakai Health Sciences Program, Entebbe, Uganda.

Associated clinical trials:

Male Circumcision for HIV Prevention in Rakai, Uganda | NCT00425984

Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community | NCT00124878

Sirolimus in Treating Patients With Glioblastoma Multiforme | NCT00047073

Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa | NCT03338699

Articles citing this

Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80

Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med (2010) 3.84

Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet (2011) 3.52

Complications of circumcision in male neonates, infants and children: a systematic review. BMC Urol (2010) 2.75

Costs and effectiveness of neonatal male circumcision. Arch Pediatr Adolesc Med (2012) 2.31

Rates of adverse events associated with male circumcision in U.S. medical settings, 2001 to 2010. JAMA Pediatr (2014) 2.01

Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. J Infect Dis (2010) 1.92

The number of procedures required to achieve optimal competency with male circumcision: findings from a randomized trial in Rakai, Uganda. BJU Int (2009) 1.84

The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr (2013) 1.74

Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda. Lancet Infect Dis (2011) 1.69

Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect (2010) 1.60

Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS (2009) 1.48

Voluntary medical male circumcision in resource-constrained settings. Nat Rev Urol (2015) 1.37

A 'snip' in time: what is the best age to circumcise? BMC Pediatr (2012) 1.36

Factors associated with the safety of voluntary medical male circumcision in Nyanza province, Kenya. Bull World Health Organ (2012) 1.25

Safety and efficacy of nontherapeutic male circumcision: a systematic review. Ann Fam Med (2010) 1.25

Male circumcision for HIV prevention: current research and programmatic issues. AIDS (2010) 1.24

Behavioral aspects of male circumcision for the prevention of HIV infection. Curr HIV/AIDS Rep (2009) 1.22

HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS (2009) 1.18

Translation of biomedical prevention strategies for HIV: prospects and pitfalls. J Acquir Immune Defic Syndr (2013) 1.12

Male circumcision, HIV and sexually transmitted infections: a review. Br J Nurs (2010) 1.11

Time to complete wound healing in HIV-positive and HIV-negative men following medical male circumcision in Kisumu, Kenya: a prospective cohort study. PLoS One (2013) 1.08

Factors associated with resumption of sex before complete wound healing in circumcised HIV-positive and HIV-negative men in Kisumu, Kenya. J Acquir Immune Defic Syndr (2013) 1.03

Safety of adult medical male circumcision performed by non-physician clinicians in Kenya: a prospective cohort study. Glob Health Sci Pract (2014) 0.97

Effect of text messaging to deter early resumption of sexual activity after male circumcision for HIV prevention: a randomized controlled trial. J Acquir Immune Defic Syndr (2014) 0.96

HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study. PLoS Med (2015) 0.95

Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission. AIDS Behav (2011) 0.93

Scaling-up voluntary medical male circumcision - what have we learned? HIV AIDS (Auckl) (2014) 0.91

Risk factors for HIV infection among circumcised men in Uganda: a case-control study. J Int AIDS Soc (2015) 0.86

Circumcision Status and Risk of HIV Acquisition during Heterosexual Intercourse for Both Males and Females: A Meta-Analysis. PLoS One (2015) 0.84

Low adverse event rates following voluntary medical male circumcision in a high HIV disease burden public sector prevention programme in South Africa. J Int AIDS Soc (2014) 0.83

Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia. J Acquir Immune Defic Syndr (2016) 0.78

What Messages are Adolescent Voluntary Medical Male Circumcision (VMMC) Clients Getting and How? Findings From an Observational Study in Tanzania. AIDS Behav (2017) 0.77

Commentary: male circumcision for prevention of heterosexual acquisition of HIV in men: perspective from a trial team. Int J Epidemiol (2010) 0.77

Voice-Message-Based mHealth Intervention to Reduce Postoperative Penetrative Sex in Recipients of Voluntary Medical Male Circumcision in the Western Cape, South Africa: Protocol of a Randomized Controlled Trial. JMIR Res Protoc (2016) 0.77

The burden of tetanus in Uganda. Springerplus (2016) 0.75

Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection. PLoS One (2016) 0.75

Could Circumcision of HIV-Positive Males Benefit Voluntary Medical Male Circumcision Programs in Africa? Mathematical Modeling Analysis. PLoS One (2017) 0.75

Articles by these authors

Health professionals for a new century: transforming education to strengthen health systems in an interdependent world. Lancet (2010) 42.10

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08

Towards a common definition of global health. Lancet (2009) 12.36

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep (2005) 8.91

Medical schools in sub-Saharan Africa. Lancet (2010) 8.85

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med (2009) 8.26

Assessing country-level efforts to link research to action. Bull World Health Organ (2006) 7.63

Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet (2008) 6.28

Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS (2005) 6.10

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials (2007) 4.93

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda. AIDS (2009) 4.54

Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet (2005) 4.51

Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis (2008) 4.48

Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36

HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS (2011) 4.26

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23

Effect of the Integrated Management of Childhood Illness strategy on childhood mortality and nutrition in a rural area in Bangladesh: a cluster randomised trial. Lancet (2009) 4.11

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS (2007) 4.09

The medical benefits of male circumcision. JAMA (2011) 4.05

Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr (2004) 3.86

Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med (2010) 3.84

The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int (2008) 3.73

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet (2005) 3.60

Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60

The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol (2008) 3.60

Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis (2006) 3.54

Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS (2009) 3.53

Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet (2011) 3.52

New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med (2011) 3.46

Domestic violence in rural Uganda: evidence from a community-based study. Bull World Health Organ (2003) 3.45